Table_2_Therapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Pasteurella multocida Capsular Type A in Mice.DOCX by Yibao Chen (5517782)

“…Depolymerase plus serum significantly reduced the number of viable wild-type P. multocida strain HB03 cells (3.5–4.5 log decrease in colony-forming units). Moreover, treatment with phage or purified depolymerase resulted in significantly increased survival of mice infected with P. multocida HB03, and an absence of increase of eosinophils and basophils or other pathological changes when compared with the control group. …”

Table_1_Therapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Pasteurella multocida Capsular Type A in Mice.DOCX by Yibao Chen (5517782)

“…Depolymerase plus serum significantly reduced the number of viable wild-type P. multocida strain HB03 cells (3.5–4.5 log decrease in colony-forming units). Moreover, treatment with phage or purified depolymerase resulted in significantly increased survival of mice infected with P. multocida HB03, and an absence of increase of eosinophils and basophils or other pathological changes when compared with the control group. …”

Image_1_Therapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Pasteurella multocida Capsular Type A in Mice.PDF by Yibao Chen (5517782)

“…Depolymerase plus serum significantly reduced the number of viable wild-type P. multocida strain HB03 cells (3.5–4.5 log decrease in colony-forming units). Moreover, treatment with phage or purified depolymerase resulted in significantly increased survival of mice infected with P. multocida HB03, and an absence of increase of eosinophils and basophils or other pathological changes when compared with the control group. …”

Table_3_Therapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Pasteurella multocida Capsular Type A in Mice.DOCX by Yibao Chen (5517782)

“…Depolymerase plus serum significantly reduced the number of viable wild-type P. multocida strain HB03 cells (3.5–4.5 log decrease in colony-forming units). Moreover, treatment with phage or purified depolymerase resulted in significantly increased survival of mice infected with P. multocida HB03, and an absence of increase of eosinophils and basophils or other pathological changes when compared with the control group. …”

The result of the secondary structure prediction of native and six mutant proteins of TP35 protein using the SOPMA server. by Ashraf Attia Mahmoud (21262201)

Percentage of Tregs infiltrating the tumor is moderately correlated with tumoral volume. by Aleida Núñez-Ruiz (12463062)

N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh₃ and IPr by Tetsuo Sato (2010571)

“…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)₂ (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)₂ (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”

N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh₃ and IPr by Tetsuo Sato (2010571)

“…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)₂ (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)₂ (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”

Table_2_Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.DOCX by Ipsita Goswami (14292725)

“…There was a trend toward decreasing CSI and DFA α1 and increasing CVI in the first 8 months of age.…”

N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh₃ and IPr by Tetsuo Sato (2010571)

“…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)₂ (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)₂ (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”

Table_1_Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.DOCX by Ipsita Goswami (14292725)

“…There was a trend toward decreasing CSI and DFA α1 and increasing CVI in the first 8 months of age.…”

N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh₃ and IPr by Tetsuo Sato (2010571)

“…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)₂ (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)₂ (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”

N‑Heterocyclic Carbenes with a <i>N</i>‑2,4-Dinitrophenyl Substituent: Comparison with PPh₃ and IPr by Tetsuo Sato (2010571)

“…Rh and Au complexesRhCl­(<b>2a</b>)­(cod) [<b>3a</b> (cod = 1,5-cyclooctadiene)], RhCl­(<b>2b</b>)­(cod) (<b>3b</b>), RhCl­(<b>2a</b>)­(CO)₂ (<b>4a</b>), RhCl­(<b>2b</b>)­(CO)₂ (<b>4b</b>), and AuCl­(<b>2a</b>) (<b>5a</b>)were synthesized using <b>2a</b>·HBr and <b>2b</b>·HOTf. …”

Supplementary Material for: Cognitive Function and White Matter Changes Associated with Renal Transplantation by Gupta A. (3236253)

“…<b><i>Background:</i></b> End-stage renal disease (ESRD) is a disease with an aging population and a high prevalence of cognitive impairment affecting quality of life, health care costs and mortality. …”

IL-17 is associated with RRV-induced arthritic disease in humans. by Helen Mostafavi (12072008)

Heatmap comparison of the highest fractional inhibitory concentration index (FICI) values and fold change (FC) reductions in colistin MIC across all tested bacterial strains. by Marian Klose (22190299)

“…(B) highlights fold changes in colistin MIC, showcasing substantial reductions, including a 32-fold decrease in <i><i>B. subtilis</i></i> (with lonafarnib) and <i><i>E. cloacae</i></i> (with both lonafarnib and tipifarnib). …”

<i>Cryptococcus neoformans</i> incubated for 8 days in hypoxia harbor a homogenous phenotype of viable but non-culturable cell (VBNC). by Benjamin Hommel (523072)

“…Compared to STAT condition (110.5% [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1007945#ppat.1007945.ref108" target="_blank">108</a>–<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1007945#ppat.1007945.ref113" target="_blank">113</a>]), the median culturability was (33.2% [31.1–35.2] at D2, 4.3% [4.0–4.6] at D4, 0.8% [0.5–1.0] at D8) in hypoxia and (28.6% [17.2–40.0] at D2, 20.3% [17.9–22.8] at D4 and 17.5% [15.4–19.7] at D8 in normoxia cells) (* p<0.01). …”

DataSheet_1_Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.pdf by Tao Ouyang (735563)

“…Hyperthyroidism (OR 3.8, 95%CI 1.7–8.6), nausea (OR 3.7, 95%CI 2.5–5.3), diarrhea (OR 2.7, 95%CI 2.2–3.2), colitis (OR 3.4, 95%CI 2.7–4.3), ALT increase (OR 4.9, 95%CI 3.9–6.1), AST increase (OR 3.8, 95%CI 3.0–4.9), pruritus (OR 2.4, 95%CI 1.5–3.9), rash (OR 2.8, 95%CI 2.1–3.8), fatigue (OR 2.8, 95%CI 2.2–3.7), decreased appetite (OR 2.4, 95%CI 1.5–3.8), and hypophysitis (OR 2.0, 95%CI 1.2–3.3) were more frequent with combined ICIs. …”

DataSheet1_A Synthesized Study of the Spatiotemporal Evolution of Central Yellow Sea Mud Depositional Processes During the Holocene.PDF by Fuchang Zhong (10889577)

“…An adjacent subarea surrounds the depocenter subarea; this subarea has mud thicknesses between 2 and 4 m, and a high mid-Holocene SR which evinces a gradually decreasing trend after 5 ka. …”

Influences of different fracture characteristics on the production temperature. by Hanbo Cui (21485713)